Encompass beats, ups guidance

 

Encompass Health beats fiscal Q2 2026 estimates with non-GAAP EPS $1.55 (+11% YoY) and revenue $1.6B (+10% YoY), raises 2026 EPS and revenue guidance

• Raised full-year 2026 adjusted EPS guidance range to $6.02–$6.25 from prior outlook
• Raised full-year 2026 revenue guidance range to $6.41–$6.49B from previously issued guidance

https://finviz.com/stock?t=EHC&p=d